Skip to content

A Comparison of Post-Sternotomy Dressings

A Comparison of Post-Sternotomy Dressings

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02198066
Enrollment
351
Registered
2014-07-23
Start date
2010-07-31
Completion date
2012-08-31
Last updated
2014-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Impaired Wound Healing, Postoperative Wound Infection-deep

Keywords

Sternotomy incision, Silver dressing, Sternal wound infection

Brief summary

The purpose of this study was to determine which of three types of dressings, a dry sterile dressing, a metallic silver dressing or an ionic silver dressing provided better patient outcomes for the post-sternotomy cardiac surgery patient population. In this prospective, randomized controlled trial, the hypothesis was that subjects who received either of the silver impregnated dressings would have better outcomes (better wound healing, less discomfort, and less incidence of infection). Investigators also evaluated dressing factors such as adherence, time for application and ease of use.

Detailed description

No other information included.

Interventions

OTHERDry Sterile Dressing

Described in Arm Description.

OTHERMetallic Silver Dressing

Described in Arm Description.

OTHERIonic Silver Dressing

Described in Arm Description.

Sponsors

DeRoyal Industries, Inc.
CollaboratorINDUSTRY
Smith & Nephew, Inc.
CollaboratorINDUSTRY
Carilion Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult (at least 21 years of age) inpatients awaiting cardiac surgery or outpatients seen in the pre-surgical testing area prior to admission for surgery * Having surgery at the study setting * English-speaking * Able to understand and give consent * Had the approval of their cardiothoracic surgeon to participate * Had no known sensitivity to silver * Had no known sensitivity to alginates

Exclusion criteria

* Known sensitivity to silver * Known sensitivity to alginates

Design outcomes

Primary

MeasureTime frameDescription
Wound Healing5 days postoperatively or day of discharge, whichever came firstThe primary outcome measure in this study was wound healing, defined as the degree of wound approximation, skin integrity, exudate, and presence/absence of necrotic tissue, assessed at postoperative day 5 or day of discharge. Wound approximation was assessed as total, partial (less than 2 centimeters of superficial separation), moderate (greater than 2 centimeters of superficial separation), or dehisced (complete separation of layers). Skin integrity was evaluated as normal (pink, no redness), inflamed, (heat, redness, swelling), or macerated within a 2.5 centimeter border of the incision. Exudate quality was assessed as purulent, blood, serosanguinous, or serous. Presence or absence of necrotic tissue was noted.

Secondary

MeasureTime frameDescription
Patient Comfort5 days postoperatively or day of hospital discharge, whichever came firstThe secondary outcome measure in this study was patient comfort with the dressing in place and upon removal. Comfort was measured using a 0-10 scale, with 0 signifying no pain and 10 signifying maximum pain.

Other

MeasureTime frameDescription
Dressing Factors5 days postoperatively or at day of discharge, whichever came firstDressing factors of ease of application, removal, and incision assessment were measured on a 5-point Likert-type scale (1=very easy, 2=moderately easy, 3=neither easy nor hard, 4=moderately hard, and 5=very hard). Dressing integrity was assessed as suture line exposed, poorly sealed (imperfect covering of the suture line with the potential for organism entry), or well-sealed.
Sternal Wound Infection30 days postoperativelyInvestigators evaluated sternal wound infection presence and type (superficial or deep) using Centers for Disease Control/National Healthcare Safety Network surveillance definitions.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026